We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

49 hedge funds and large institutions have $94M invested in Genocea Biosciences, Inc. in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,055% more call options, than puts

Call options by funds: $127K | Put options by funds: $11K

200% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 5

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

47% more capital invested

Capital invested by funds: $64M → $94M (+$30M)

4% more funds holding

Funds holding: 47 → 49 (+2)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
49
Holders Change
+2
Holders Change %
+4.26%
% of All Funds
1.22%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
15
Reduced
5
Closed
7
Calls
$127K
Puts
$11K
Net Calls
+$116K
Net Calls Change
+$85K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$1.41M
2
WA
Wasatch Advisors
Utah
+$484K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$376K
4
JP Morgan Chase
JP Morgan Chase
New York
+$174K
5
BCM
Bridgeway Capital Management
Texas
+$156K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$1.02M
2
NC
Northpointe Capital
Michigan
-$865K
3
SFM
Sphera Funds Management
Israel
-$244K
4
VKH
Virtu KCG Holdings
New York
-$225K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$107K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$26M +$90.7K +2,322 +0.4%
Franklin Resources
2
Franklin Resources
California
$18.2M – – –
PVMCV
3
Polaris Venture Management Co V
Massachusetts
$12M – – –
NC
4
Northpointe Capital
Michigan
$7.42M -$865K -22,136 -13%
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.58M +$376K +9,632 +11%
SFM
6
Sphera Funds Management
Israel
$3.94M -$244K -6,250 -7%
Axa
7
Axa
France
$3.7M +$6.53K +167 +0.2%
RSCM
8
Rock Springs Capital Management
Maryland
$2.92M – – –
DM
9
Deerfield Management
New York
$2.92M -$1.02M -26,032 -30%
AA
10
AlphaMark Advisors
Kentucky
$1.86M +$313 +8 +0%
BlackRock
11
BlackRock
New York
$1.76M +$1.41M +36,096 New
Alyeska Investment Group
12
Alyeska Investment Group
Illinois
$1.36M -$12.8K -328 -1%
Principal Financial Group
13
Principal Financial Group
Iowa
$1.33M – – –
BCM
14
Bridgeway Capital Management
Texas
$920K +$156K +4,000 +27%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$903K +$32.7K +838 +5%
WA
16
Wasatch Advisors
Utah
$603K +$484K +12,378 New
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$365K – – –
Millennium Management
18
Millennium Management
New York
$321K -$95.9K -2,455 -27%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$313K – – –
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$271K +$123K +3,149 +131%
Northern Trust
21
Northern Trust
Illinois
$251K +$29.3K +749 +17%
BC
22
Birchview Capital
Vermont
$238K – – –
JP Morgan Chase
23
JP Morgan Chase
New York
$217K +$174K +4,464 New
SCM
24
Segantii Capital Management
Hong Kong
$160K +$128K +3,287 New
KeyBank National Association
25
KeyBank National Association
Ohio
$147K +$118K +3,027 New
1
2 3

GNCA Hedge Fund Activity: Q1 2017 in Review

49 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q1 2017, worth a combined $94M — up 47% from $64M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new GNCA positions and 7 closed out — a net gain of 6 holders — while 15 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $1.41M. The largest seller was Deerfield Management, cutting an estimated $1.02M.

  • 49 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q1 2017, up from 47 in Q4 2016.
  • Funds reported $94M of Genocea Biosciences, Inc. stock for Q1 2017, up 47% quarter-over-quarter.
  • 13 funds opened new Genocea Biosciences, Inc. positions in Q1 2017 and 7 closed out, a net change of +6 holders.
  • The largest Genocea Biosciences, Inc. buyer in Q1 2017 was BlackRock, an estimated $1.41M added.
  • The largest Genocea Biosciences, Inc. seller in Q1 2017 was Deerfield Management, an estimated $1.02M sold.

Based on aggregated 13F filings for Q1 2017.